DSM-FIRMENICH
Add to a list
To use this feature you must be a member
Log inSign up
DSFI
CH1216478797
Consumer Goods Conglomerates End-of-day quote Wiener Boerse Other stock markets | 5-day change | 1st Jan Change | ||
104.7 EUR | -0.57% | | -0.48% | +13.31% |
May. 31 | Dsm-firmenich to Build Centralized Financing Structure Under Cross Guarantee Deal | MT |
May. 28 | Elanco Says FDA Confirms Bovaer Meets Safety, Efficacy Requirements | MT |
Financials
Sales 2024 * | 12.62B 13.68B | Sales 2025 * | 13.27B 14.39B | Capitalization | 28.03B 30.4B |
---|---|---|---|---|---|
Net income 2024 * | 453M 491M | Net income 2025 * | 810M 878M | EV / Sales 2024 * | 2.46x |
Net Debt 2024 * | 2.95B 3.2B | Net Debt 2025 * | 2.69B 2.92B | EV / Sales 2025 * | 2.32x |
P/E ratio 2024 * | 60.7x | P/E ratio 2025 * | 34.8x | Employees | 28,685 |
Yield 2024 * | 2.38% | Yield 2025 * | 2.34% | Free-Float | 25.03% |
More Fundamentals * Assessed data
Chart DSM-Firmenich
Dynamic Chart
Latest news about DSM-Firmenich
Dsm-firmenich to Build Centralized Financing Structure Under Cross Guarantee Deal | MT | |
Elanco Says FDA Confirms Bovaer Meets Safety, Efficacy Requirements | MT | |
Dsm-Firmenich Ag Approves Retirement of Pradeep Pant from the Board | CI | |
Dsm-Firmenich Ag Approves the Dividend, Payable May 16, 2024 | CI | |
Tranche Update on DSM-Firmenich AG's Equity Buyback Plan announced on April 8, 2024. | CI | |
DSM-Firmenich AG's Equity Buyback announced on April 8, 2024, has closed with 1,500,000 shares, representing 0.57% for ?156.59 million. | CI | |
Global markets live: Etsy, Qualcomm, Carvana, Rio Tinto, Apple... | ![]() | |
DSM-FIRMENICH : Vitamin trouble is going to fade | ![]() | |
U.S. Futures Up, European Stocks Mixed in Wake of Fed Remarks | DJ | |
Transcript : DSM-Firmenich AG, Q1 2024 Sales/ Trading Statement Call, May 02, 2024 | ||
U.S. Futures Down, European Stocks Mixed | DJ | |
DSM-Firmenich AG announces an Equity Buyback for 1,500,000 shares, representing 0.6% of its issued share capital. | CI | |
DSM-Firmenich AG authorizes a Buyback Plan. | CI | |
DSM-FIRMENICH : A stronger long-term outlook | ![]() | |
Quiz sales fall, names new CEO; Byotrol eyes AIM exit | AN |
More news
Latest transcript on DSM-Firmenich
DSM-Firmenich AG, Q1 2024 Sales/ Trading Statement Call, May 02, 2024
More transcripts
Analyst Recommendations on DSM-Firmenich
DSM-FIRMENICH : Vitamin trouble is going to fade | ![]() | |
DSM-FIRMENICH : A stronger long-term outlook | ![]() | |
DSM-FIRMENICH : Some mess from the combination | ![]() | |
DSM-FIRMENICH : An even pure(er) play | ![]() | |
DSM-FIRMENICH : Awaiting the recovery | ![]() |
More recommendations
Press releases DSM-Firmenich
Danube : DSM Firmenich AG, DSM B.V. publishes 2023 Annual Report | PU | |
Danube : DSM-Firmenich AG, - Share repurchase program to cover share plans completed | PU | |
Danube : DSM-Firmenich AG, - dsm-firmenich completes on-market repurchase of 500,000 shares to cover share plans | PU | |
OTC Markets Group Welcomes DSM Firmenich AG to OTCQX | AQ | |
Danube : DSM-Firmenich AG, - dsm-firmenich completes the divestiture of its Jiangshan Vitamin C plant in China | PU |
More press releases
News in other languages on DSM-Firmenich
Bovaer zorgt voor stevige groei DSM-Firmenich | ||
DSM-Firmenich krijgt groen licht FDA voor Bovaer | ||
Barclays verhoogt koersdoel DSM-Firmenich | ||
Tu-sais-qui publie ce soir | ||
AVIS D'ANALYSTES DU JOUR : Airbus, Sartorius Stedim Biotech, AB Inbev, Rémy Cointreau, Soitec... |
More news
Quotes and Performance
1 day | -0.57% | ||
1 week | -0.48% | ||
1 month | -1.55% | ||
3 months | +5.57% | ||
6 months | +20.29% | ||
Current year | +13.31% |
More quotes
Highs and lows
1 week
104.70
107.30
1 month
103.45
108.15
Current year
87.22
108.35
1 year
76.22
108.35
3 years
76.22
108.35
5 years
76.22
108.35
10 years
76.22
108.35
More quotes
Managers and Directors - DSM-Firmenich
Managers | Title | Age | Since |
---|---|---|---|
Dimitri de Vreeze CEO | Chief Executive Officer | 57 | 89-12-31 |
Ralf Schmeitz DFI | Director of Finance/CFO | - | 23-08-31 |
Sarah Reisinger CTO | Chief Tech/Sci/R&D Officer | 45 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Frits Dirk van Paasschen BRD | Director/Board Member | 63 | 23-01-31 |
Thomas Leysen CHM | Chairman | 63 | 23-01-31 |
Patrick Firmenich BRD | Director/Board Member | 62 | 23-01-31 |
More insiders
Quotes
Date | Price | Change |
---|---|---|
24-05-31 | 104.7 | -0.57% |
24-05-30 | 105.3 | -0.85% |
24-05-29 | 106.2 | -1.03% |
24-05-28 | 107.3 | +1.08% |
24-05-27 | 106.2 | +0.90% |
End-of-day quote Wiener Boerse, May 30, 2024
More quotes
Company Profile
DSM-Firmenich AG is a leading innovator in nutrition, health, and beauty. It reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world's growing population to thrive. With a comprehensive range of natural and renewable ingredients and renowned science and technology capabilities, the company uniquely works to create what is essential for life, desirable for consumers, and more sustainable for the planet.
Sector
Consumer Goods Conglomerates
Calendar
2024-06-02 - Capital Markets Day
Related indices
STOXX EUROPE 600 (EUR) , AEX
More about the company
Income Statement Evolution
More financial data
Analysis / Opinion
More Strategies
Ratings for DSM-Firmenich
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
105.6EUR
Average target price
121.9EUR
Spread / Average Target
+15.35%
Consensus
EPS Revisions
Estimates Revisions
Quarterly earnings - Rate of surprise
Company calendar
Sector Consumer Goods Conglomerates
1st Jan change | Capi. | |
---|---|---|
BERKSHIRE HATHAWAY INC. | +15.62% | 896B |
INTERNATIONAL HOLDING COMPANY | +1.88% | 243B |
GE AEROSPACE | +29.39% | 181B |
HITACHI, LTD. | +58.75% | 95.16B |
ILLINOIS TOOL WORKS INC. | -7.33% | 72.44B |
3M COMPANY | -8.40% | 55.41B |
MITSUBISHI ELECTRIC CORPORATION | +36.57% | 36.26B |
ALPHA DHABI HOLDING | -42.23% | 29.56B |
MITSUBISHI HEAVY INDUSTRIES, LTD. | +66.00% | 29.24B |
Consumer Goods Conglomerates
- Stock Market
- Equities
- DSFIR Stock
- DSFI Stock